Early Outcomes From Lutetium Lu-177 Vipivotide Tetraxetan Treatment in Patients Selected for Therapy With Piflufolastat F-18 PET Imaging

Authors

Thomas P. Boike, Beaumont Health
Vincent A. DiPippo
Heather Austin
Wendy Turnquist
Yusuf Qamruzzaman, Beaumont Health

Document Type

Conference Proceeding

Publication Date

2-2023

Publication Title

Journal of Clinical Oncology

Volume

41

Issue

6 Suppl

First Page

191

Comments

American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, February 16-18, 2023, San Francisco, CA

Recommended Citation

Boike TP, DiPippo VA, Austin H, Turnquist W, Qamruzzaman Y. Early outcomes from lutetium Lu-177 vipivotide tetraxetan treatment in patients selected for therapy with piflufolastat F-18 PET imaging. J Clin Oncol. 2023 Feb;41(6 Suppl):191. doi:10.1200/JCO.2023.41.6_suppl.191

DOI

10.1200/JCO.2023.41.6_suppl.191